Quantum Biopharma Ltd (QNTM)

Apr 27, 2026

Quantum BioPharma Provides Corporate Update - GlobeNewswire

Apr 27, 2026

Apr 27, 2026

Top Cannabis Stocks To Follow NowApril 27th - MarketBeat

Apr 27, 2026

Apr 27, 2026

Quantum Biopharma buys additional $1 million of Bitcoin, other cryptocurrencies - MSN

Apr 27, 2026

Apr 24, 2026

QNTM Should I Buy - Intellectia AI

Apr 24, 2026

Apr 24, 2026

Quantum Biopharma bolsters Bitcoin treasury - MSN

Apr 24, 2026

Apr 24, 2026

Quantum BioPharma announces private placement - MSN

Apr 24, 2026

Apr 22, 2026

Cannabis Stocks To Watch NowApril 22nd - MarketBeat

Apr 22, 2026

Apr 22, 2026

Quantum BioPharma’s Unbuzzd Licensee Names New CEO to Drive U.S. Rollout of Clinically Backed Hangover Beverage - TipRanks

Apr 22, 2026

Apr 22, 2026

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Appoints Richard Buzbuzian as CEO to Lead Nationwide Commercialization of Innovative, Clinically Validated Hangover Remedy and Alcohol Metabolism Accelerant - The Manila Times

Apr 22, 2026

Apr 22, 2026

Unbuzzd’s new CEO to drive U.S. rollout for Quantum BioPharma (NASDAQ: QNTM) - Stock Titan

Apr 22, 2026

Apr 22, 2026

Quantum BioPharma Ltd. Announces Appointment of Richard Buzbuzian as CEO of Unbuzzd Wellness Inc. to Drive Commercialization of Innovative Beverage - Quiver Quantitative

Apr 22, 2026

Apr 21, 2026

Promising Cannabis Stocks To Follow TodayApril 21st - MarketBeat

Apr 21, 2026

Apr 20, 2026

Quantum (QNTM) Stock: Momentum Behavior Insight (Slight Rise) 2026-04-20Shared Buy Zones - Cổng thông tin điện tử Tỉnh Sơn La

Apr 20, 2026

Apr 12, 2026

Press Releases about Royal Bank of Canada (Toronto Stock Exchange:RY) - FinancialContent

Apr 12, 2026

Apr 10, 2026

Value Recap: Should I invest in Quantum BioPharma Ltd before earnings2026 News Drivers & Technical Buy Zone Confirmation - baoquankhu1.vn

Apr 10, 2026

Apr 10, 2026

Operating expenses (excl. COGS) of Quantum Biopharma Ltd. Subordinate Voting Shares Class B – HAM:0K91 - TradingView — Track All Markets

Apr 10, 2026

Apr 09, 2026

Whats the fair value of Quantum BioPharma Ltd stockWeekly Gains Report & Risk Managed Investment Entry Signals - baoquankhu1.vn

Apr 09, 2026

Apr 08, 2026

Recap Report: Can Quantum BioPharma Ltd generate free cash flow2026 Historical Comparison & Stock Timing and Entry Methods - baoquankhu1.vn

Apr 08, 2026

Apr 07, 2026

Quantum Biopharma Receives Nasdaq Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement and Completes Debt Settlements - ACCESS Newswire

Apr 07, 2026

Apr 06, 2026

Can Quantum (QNTM) Stock Beat Estimates | Price at $3.58, Down 10.05%Community Trade Ideas - Cổng thông tin điện tử tỉnh Lào Cai

Apr 06, 2026

Apr 04, 2026

Top Cannabis Stocks To Watch NowApril 4th - MarketBeat

Apr 04, 2026

Apr 04, 2026

QNTM Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Apr 04, 2026

Apr 04, 2026

Quantum BioPharma Ltd. (QNTM) Stock Price, News, Quote & History - Yahoo! Finance Canada

Apr 04, 2026

Apr 04, 2026

Quantum BioPharma Ltd. (QNTM) stock price, news, quote and history - Yahoo Finance UK

Apr 04, 2026

Apr 03, 2026

Quantum BioPharma Wins Significant Court Challenge in USD $700,000,000 Claim as Defendants Joint Motion to Dismiss Lawsuit Alleging Market Manipulation by CIBC World Markets and RBC Dominion Securities is Denied - Sahm

Apr 03, 2026

Apr 02, 2026

Quantum Biopharma Ltd. (QNTM) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Apr 02, 2026

Apr 02, 2026

Cannabis Stocks To Watch TodayApril 2nd - MarketBeat

Apr 02, 2026

Apr 02, 2026

Quantum BioPharma Cleared to Proceed With $700 Million Market Manipulation Lawsuit After Motion to Dismiss Largely Denied - TipRanks

Apr 02, 2026

Apr 02, 2026

[6-K] Quantum Biopharma Ltd. Current Report (Foreign Issuer) | QNTM SEC FilingForm 6-K - Stock Titan

Apr 02, 2026

Apr 02, 2026

Quantum BioPharma submits IND application for MS drug candidate By Investing.com - Investing.com South Africa

Apr 02, 2026

Apr 02, 2026

Quantum BioPharma Submits Investigational New Drug (IND) Application to United States Food and Drug Administration (FDA) for Lucid-MS Phase Two Clinical Trial in Multiple Sclerosis - Sahm

Apr 02, 2026

Apr 01, 2026

Quantum BioPharma (QNTM) Files FDA Application for New MS Drug - GuruFocus

Apr 01, 2026

Apr 01, 2026

Quantum BioPharma up 5% as Submits IND Application For Lucid-MS - marketscreener.com

Apr 01, 2026

Apr 01, 2026

Quantum BioPharma Files FDA IND for Phase 2 Trial of Lucid-MS in Multiple Sclerosis - TipRanks

Apr 01, 2026

Apr 01, 2026

Quantum BioPharma submits investigational new drug (IND) application to United States Food and Drug Administration (FDA) - marketscreener.com

Apr 01, 2026

Apr 01, 2026

Quantum BioPharma submits IND application for MS drug candidate - Investing.com

Apr 01, 2026

Apr 01, 2026

Quantum BioPharma (QNTM) advances Lucid-MS with FDA IND for Phase 2 MS trial - Stock Titan

Apr 01, 2026

Mar 31, 2026

BioPharma Spoofing Suit Against Canadian Banks Proceeds - Law360

Mar 31, 2026